Welcome to the Hope Bio Blog

Written by Jan Shultis Sugar Land, Texas, 1 NOV 2024: Hope Biosciences, a clinical-stage biotechnology company that manufactures mesenchymal stem cell therapeutics through proprietary technology unprecedented in its ability to create repeatable treatments, today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences’ adipose‑derived autologous mesenchymal stem cell therapy (HB-adMSCs) for patients with mild to moderate relapsing remitting m